The Oncology Institute Inc (TOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,565 | 27,658 | 30,292 | 39,739 | 49,669 |
| Receivables | 59,320 | 59,978 | 55,935 | 49,666 | 48,681 |
| Inventories | 16,875 | 18,882 | 15,786 | 12,308 | 10,039 |
| TOTAL | $112,747 | $110,092 | $104,792 | $106,820 | $112,418 |
| Non-Current Assets | |||||
| PPE Net | 10,684 | 10,714 | 10,854 | 11,116 | 11,888 |
| Intangibles | 18,245 | 18,962 | 19,679 | 21,266 | 22,040 |
| Other Non-Current Assets | 22,980 | 23,851 | 24,473 | 24,800 | 26,371 |
| TOTAL | $51,909 | $53,527 | $55,006 | $57,182 | $60,299 |
| Total Assets | $164,656 | $163,619 | $159,798 | $164,002 | $172,717 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 43,167 | 35,634 | 34,933 | 29,291 | 24,324 |
| Accrued Expenses | 20,639 | 22,785 | 22,892 | 23,434 | 21,093 |
| TOTAL | $70,962 | $65,580 | $64,778 | $59,541 | $52,215 |
| Non-Current Liabilities | |||||
| Long Term Debt | 77,400 | 76,195 | 75,023 | 73,894 | 93,131 |
| Other Non-Current Liabilities | 32,014 | 34,118 | 28,982 | 25,466 | 23,750 |
| TOTAL | $109,414 | $110,313 | $104,005 | $99,392 | $116,913 |
| Total Liabilities | $180,376 | $175,893 | $168,783 | $158,933 | $169,128 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 98,839 | 98,381 | 93,505 | 89,234 | 75,753 |
| Common Shares | 10 | 10 | 9 | 9 | 8 |
| Retained earnings | -271,419 | -263,911 | -247,407 | -230,398 | -210,813 |
| Other shareholders' equity | -19 | -19 | -19 | -19 | -19 |
| TOTAL | $-15,720 | $-12,274 | $-8,985 | $5,069 | $3,589 |
| Total Liabilities And Equity | $164,656 | $163,619 | $159,798 | $164,002 | $172,717 |